Neuphoria Therapeutics Inc. (NEUP) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Neuphoria Therapeutics Inc. (NEUP) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $18.3M, listed on NASDAQ, employing roughly 1 people, carrying a beta of 0.75 to the broader market. Neuphoria Therapeutics, Inc. Led by Spyridon Papapetropoulos, public since 2021-12-16.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for NEUP as of 2026-10-15; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →